Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluefield Solar Regulatory News (BSIF)

Share Price Information for Bluefield Solar (BSIF)

Share Price is delayed by 15 minutes
Get Live Data
91.50    0.00 (0.00%)
Bid:
91.40
Ask:
91.60
Spread: 0.20 (0.219%)
Market Cap: £541.75m
BSIF Live PriceLast checked at - London Stock Exchange

Intraday Bluefield Solar Share Chart

Form 8.3

12 Feb 2026 15:25

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity Fund)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Bluefield Solar Income Fund Limited

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11 February 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

0.01p ordinary – 592,080,033

(ISIN: GG00BB0RDB98)

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Cash-settled derivatives:

6,058,327

1.02%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

6,058,327

1.02%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

N/A

N/A

N/A

N/A

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

0.01p ordinary

CFD

Reducing a long position

200,000

GBP 0.7610

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.

If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

No

Date of disclosure:

12 February 2026

Contact name:

Mary Merrigan

Telephone number:

+1 617 778 7775

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260212174939/en/

Copyright Business Wire 2026

Date   Source Headline
23rd Aug 20235:03 pmRNSDirector/PDMR Shareholding
18th Aug 202312:10 pmRNSDirector/PDMR Shareholding
18th Aug 202312:08 pmRNSDirector/PDMR Shareholding
17th Aug 20233:58 pmRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSUnaudited Net Asset Value as of 30 June 2023
7th Aug 202312:12 pmRNSThird Interim Dividend Announcement - Replacement
7th Aug 20237:00 amRNSThird Interim Dividend Announcement
22nd Jun 20237:00 amRNSRCF Increase and Extension
7th Jun 20237:00 amRNSConclusion of Audit Tender Process
18th May 20235:21 pmRNSChange to Director Roles and Responsibilities
11th May 20237:00 amRNSUnaudited NAV 31 Mar 2023 and 2nd Interim Dividend
2nd May 20237:00 amRNSRe-Financing, Increase & Extension of NatWest Loan
17th Mar 20239:44 amRNSDirector Declaration
8th Mar 20237:00 amRNSChange of Registrar
28th Feb 20237:00 amRNSInterim Results to 31 December 2022
22nd Feb 20233:28 pmRNSDirector Retirement
6th Feb 20237:00 amRNSNotice of Interim Results
23rd Jan 20237:00 amRNSFirst Interim Dividend
12th Jan 202312:32 pmRNSUpdate research from QuotedData
9th Jan 20233:32 pmRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSAcquisition of 46.4MWp Solar Portfolio
8th Dec 20225:45 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:52 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSChange to Director Roles & Responsibilities
29th Nov 20224:32 pmRNSResult of AGM
22nd Nov 20227:00 amRNSSept 22 NAV, Autumn Statement & Development Update
1st Nov 20227:00 amRNSNotice of AGM
20th Oct 20222:20 pmRNSDirector/PDMR Shareholding
17th Oct 20223:01 pmRNSDirector/PDMR Shareholding
14th Oct 20224:27 pmRNSDirector/PDMR Shareholding
14th Oct 20222:03 pmRNSDirector/PDMR Shareholding
13th Oct 20225:02 pmRNSDirector/PDMR Shareholding
7th Oct 20221:37 pmRNSDirector Appointment
6th Oct 20221:57 pmRNSDirector/PDMR Shareholding
4th Oct 20221:59 pmRNSDirector/PDMR Shareholding
3rd Oct 20223:56 pmRNSDirector/PDMR Shareholding
30th Sep 20225:11 pmRNSDirector/PDMR Shareholding
30th Sep 20227:01 amRNSFourth Interim Dividend Announcement
30th Sep 20227:00 amRNSAnnual Report for the Year Ended 30 June 2022
29th Sep 20227:00 amRNSChange to Director Roles and Responsibilities
23rd Sep 20227:00 amRNSPromotion to the FTSE 250
23rd Sep 20227:00 amRNSPromotion to the FTSE 250
22nd Sep 202210:49 amRNSDirector Notification
15th Sep 202211:31 amRNSDirector Declaration
22nd Aug 20227:00 amRNSUNAUDITED NET ASSET VALUE AS OF 30 JUNE 2022
17th Aug 202212:10 pmRNSThird Interim Dividend
15th Aug 20227:00 amRNS62.4MW Solar Contracts for Difference Secured
2nd Aug 20227:00 amRNSThird Interim Dividend
1st Jul 20227:00 amRNSTotal Voting Rights
28th Jun 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.